Japan’s first medical cannabis law may end up only legalising a single pharmaceutical product, while also criminalising recreational cannabis consumption.

The country could soon have its first medical cannabis regulation in place, allowing in theory for the use of cannabinoid-based approved medical drugs.

A new bill, which has been passed by the House of Representatives (the lower house of the Japanese parliament, or National Diet), has now been sent to the House of Councillors (the upper house) and is expected to come into effect by the end of 2024.

Read full article
I'm already a subscriber

Tiziana Cauli

Senior reporter
Tiziana is an Italian journalist from Sardinia. She has worked for both international and local media in Italy, South Africa, France, Spain, the UK, Lebanon and Belgium. She also worked as a communications manager for several international NGOs in the humanitarian sector.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization